The global anti-hypertensive drugs market is anticipated to grow at a CAGR of over 4% during the forecast period. The anti-hypertensive drugs are used to restrict any complications of high blood pressure including myocardial infarction, stroke, and many more. In addition to this, anti-hypertensive drugs have their primary action on systemic vascular resistance and it also reduces systemic vascular resistance with long-term use. Moreover, hypertension is directly associated with increased cardiovascular risk, and reducing blood pressure and the use of the anti-hypertensive drug is recommended which significantly decreases such risks. Hence, factors such as increasing cases of diabetes, hypertension, cardiovascular diseases associated with high blood pressure will directly impact the growth of the global anti-hypertensive market during the forecast period.

Request a Free Sample of our Anti-Hypertensive Drugs Market: https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market

However, the high cost associated with anti-hypertensive drugs will turn out to be a major restraint for the growth of the anti-hypertensive market, as it has to be given to the patient for a longer period. Additionally, the low awareness and less diagnosis rate in the developing countries will also hamper the growth of the anti-hypertensive drugs market during the forecast period. Moreover, the side effects of anti-hypertensive drugs such as calcium channel blockers used during pregnancy include tachycardia, palpitations, peripheral edema, headaches, and facial flushing, which will lower the adoption of these drugs. Hence, the low adoption rate of anti-hypertensive drugs during pregnancy will majorly restrict the growth of the anti-hypertensive drug market during the forecast period.

A full Report of Anti-Hypertensive Drugs Market is Available at: https://www.omrglobal.com/industry-reports/anti-hypertensive-drugs-market
Anti-Hypertensive Drugs Market Segmentation

By Drug Class

• Thiazide Diuretics
• Calcium Channel Blockers
• ACE Inhibitors
• Angiotensin II Receptor Antagonists (ARBS)
• Beta Blockers
• Others

Regional Analysis

• North America
• United States
• Canada
• Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
• Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
• Rest of the World

Company Profiles

• AstraZeneca PLC
• Bayer AG
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Co., Ltd.
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Merck KGaA
• Noden Pharma DAC
• Novartis International AG
• Pfizer Inc.
• Ranbaxy Laboratories Ltd.
• Renata Ltd.
• Sanofi S.A.
• Sun Pharmaceuticals LLC
• Takeda Pharmaceutical Company Ltd.
• Teva Pharmaceutical Industries Ltd.
• Unichem Laboratories Ltd.
• United Therapeutics Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anti-hypertensive-drugs-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 7803040404